| AXSOME THERAPEUT. DL-0001 |
| USA |
| Gesundheit |
| US05464T1043 / A2AA7B |
| 19X (Frankfurt) / AXSM (NASDAQ) |
| FRA:19X, ETR:19X, 19X:GR, NASDAQ:AXSM |
| - |
| https://axsome.com/ |
|
Axsome Therapeutics, Inc. is a commercial-stage bi..
>Volltext.. |
| 6389.45 Mio. EUR |
| 6298.48 Mio. EUR |
| 478.1 Mio. EUR |
| -158.52 Mio. EUR |
| -195.52 Mio. EUR |
| -3.98 EUR |
| 186.21 Mio. EUR |
| 277.07 Mio. EUR |
| -86 Mio. EUR |
| 0.9 |
| 57.35% |
| 29.96% |
| - |
| - |
| - |
| AXSOME |
| 02.01.26 |
|